Endovascular Treatment for Cerebral Venous Sinus Thrombosis: Comparison among Different Endovascular Procedures

医学 血管内治疗 脑静脉窦血栓形成 静脉血栓形成 血栓形成 放射科 外科 动脉瘤
作者
Anush Rangarajan,Dileep Ramachandran,Trinath Kumar Mishra,Vidhya Gunaseelan,Gopal Krishna Dash,Vivek Jacob Philip,Radhika Manohar,Kuldeep Shetty,Pavin Thomas,Vikram Huded
出处
期刊:Annals of Indian Academy of Neurology [Medknow Publications]
卷期号:27 (2): 140-145
标识
DOI:10.4103/aian.aian_965_23
摘要

Background: Cerebral venous sinus thrombosis (CVST) is a rare, treatable cause of stroke. Even though CVST has an established medical treatment, 15% of patients remain refractory to treatment. These patients may be candidates for endovascular treatment (EVT), yet the selection of patients remains a challenge. The study aims to understand the profile and outcome of patients treated with EVT and the type of procedure associated with good outcomes. Methods: This is a single-center, retrospective analysis of CVST patients who underwent EVT from 2009 till 2022. Patients who received only medical management were excluded. Modified Rankin Scale (mRS) ≤2 at 3 months was taken as the primary outcome. Secondary outcomes assessed were hospital stay, death, recurrence, mRS ≤ 2 at discharge, and angiographic recanalization. Results: Fifty-two patients were included. Twenty-eight (53.8%) were males; the mean age was 33.3 ± 12.3 years. Headache ( n = 44, 84.6%) predominated among the symptoms. The common risk factors were anemia ( n = 13, 25.5%) and hyperhomocysteinemia ( n = 13, 25.5%). Worsening of sensorium ( n = 21, 40.3%) and non-improvement of symptoms ( n = 15, 28.8%) were the common indications for the procedure. Twenty-five (48.1%) people underwent in situ thrombolysis (IST). Death occurred in eight (15.3%) patients. Thirty-six (73.5%; 36/49) patients had a good outcome at 3 months. IST had a significantly better outcome (mRS ≤ 2, n = 20, 80%) compared to other procedures ( P = 0.04). Hospital stay was lesser in the IST subgroup, but without statistical significance. Midline shift >5 mm (odds ratio [OR] 6.8 [1.5–30.9], P = 0.01) and Glasgow Coma Scale <9 before the procedure (OR 27.2 [3.1–236.4], P = 0.002) predicted bad outcomes at 3 months. Female gender (OR 4.5 [1.07–8.8], P = 0.03), presence of altered sensorium (OR 10.2 [1.2–87.5], P = 0.01), encephalopathic syndrome ( P = 0.02), presence of parenchymal bleed (OR 3.7 [0.9–4.5], P = 0.04), and midline shift (OR 4.8 [1.1–20.2], P = 0.03) were associated with poor outcome at discharge. Conclusion: EVT yielded good outcomes in carefully selected, medically refractory patients of CVST. IST performed well compared to other procedures.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
隐形曼青应助一口蒜苗采纳,获得15
刚刚
任性的小C发布了新的文献求助10
1秒前
1秒前
月月鸟发布了新的文献求助10
2秒前
2秒前
奋斗发布了新的文献求助10
2秒前
2秒前
着急的猴完成签到,获得积分10
2秒前
2秒前
烟花应助幸福的雪枫采纳,获得10
3秒前
3秒前
4秒前
雪山飞龙发布了新的文献求助10
4秒前
5秒前
5秒前
媛小媛啊完成签到,获得积分20
5秒前
5秒前
7秒前
7秒前
yyl发布了新的文献求助10
7秒前
so完成签到,获得积分10
7秒前
唐鹿发布了新的文献求助10
7秒前
7秒前
daniel发布了新的文献求助10
8秒前
良辰完成签到,获得积分10
8秒前
9秒前
9秒前
共享精神应助香蕉秋蝶采纳,获得10
9秒前
YeMa发布了新的文献求助10
9秒前
李爱国应助月月鸟采纳,获得10
10秒前
奋斗完成签到,获得积分20
10秒前
so发布了新的文献求助10
10秒前
eyrefa发布了新的文献求助10
11秒前
张沐金发布了新的文献求助10
11秒前
白藏主发布了新的文献求助10
12秒前
yu完成签到,获得积分10
12秒前
华仔应助吃不了八碗采纳,获得10
12秒前
orixero应助yyl采纳,获得10
13秒前
小泥娃发布了新的文献求助10
13秒前
范范完成签到,获得积分20
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
List of 1,091 Public Pension Profiles by Region 1581
Encyclopedia of Agriculture and Food Systems Third Edition 1500
以液相層析串聯質譜法分析糖漿產品中活性雙羰基化合物 / 吳瑋元[撰] = Analysis of reactive dicarbonyl species in syrup products by LC-MS/MS / Wei-Yuan Wu 1000
Lloyd's Register of Shipping's Approach to the Control of Incidents of Brittle Fracture in Ship Structures 800
Biology of the Reptilia. Volume 21. Morphology I. The Skull and Appendicular Locomotor Apparatus of Lepidosauria 600
Pediatric Nutrition 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 物理化学 基因 遗传学 催化作用 冶金 量子力学 光电子学
热门帖子
关注 科研通微信公众号,转发送积分 5548123
求助须知:如何正确求助?哪些是违规求助? 4633417
关于积分的说明 14631222
捐赠科研通 4575059
什么是DOI,文献DOI怎么找? 2508825
邀请新用户注册赠送积分活动 1485072
关于科研通互助平台的介绍 1456096